-
Examining the Opportunity Costs Due to Diabetic Macular Edema Taking Into Account Access Barriers Evaluated in the Barometer Program Survey in Colombia
Sep 9, 2025, 16:22 PM -
Estimating the Clinical and Economic Value of Aztreonam-Avibactam for the Treatment of Metallo-Beta-Lactamase–Producing Carbapenem- Resistant Enterobacterales Infections in China: Adopting the STEDI Value Framework
Sep 9, 2025, 16:22 PM -
Long-Term Economic Impact of Nonpersistence to Disease-Modifying Therapies in a Cohort of German Patients With Multiple Sclerosis
Sep 9, 2025, 16:22 PM -
Impact of Disease Progression on Healthcare Resource Utilization and Quality of Life in Patients With Hypertrophic Cardiomyopathy: A Real-World Cross-Sectional Survey
Sep 9, 2025, 16:22 PM -
HTA Requirements for Medical Technologies in Germany
Sep 9, 2025, 16:22 PM -
Delayed Access to Diabetes Technology in Children With Migration Background: A Cross-Sectional Study on Treatment Equity in Austria
Sep 9, 2025, 16:22 PM -
Bridging National and EU HTA Regulation: Policy Responses to the JCA Rollout
Sep 9, 2025, 16:22 PM -
HTA for Obesity and T2DM Indications: A Review and Recommendations for Future Appraisals
Sep 9, 2025, 16:22 PM -
Estimating the Economic Burden of DLBCL: Developing and Testing a Cost of Disease Model
Sep 9, 2025, 16:22 PM -
Do Health Technology Assessments (HTA) Consider Racial Health Inequalities? A Case Study of NICE HTAs for Chronic Kidney Disease Hypertension and Diabetes
Sep 9, 2025, 16:22 PM -
Through a Glass Darkly: The What, How, and What Now for Global Net Price Transparency
Sep 9, 2025, 16:22 PM -
A Strategic National Framework for Managed Entry Agreements to Access Innovative and Breakthrough Medications in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Assessing the Impact of Technology-Powered, Pharmacy- and Nursing-Supported Direct Oral Anticoagulant Management
Sep 9, 2025, 16:22 PM -
From Evidence Gaps to Launch Delays: A Review of Health Technology Assessment Critiques and Health Economics and Outcomes Research Strategy Readiness
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Introducing the Elecsys® PRO-C3 Assay as Part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK
Sep 9, 2025, 16:22 PM -
Modeling the Long-Term Bone Health Impact of TDF/FTC PrEP in Adolescent MSM
Sep 9, 2025, 16:22 PM -
Understanding the Impact of Equality and Equity Considerations on NICE Highly Specialized Technology (HST) Decision Making
Sep 9, 2025, 16:22 PM -
Costs and Their Impacts That Should Be Included in Health Technology Assessment of Remote Palliative Care
Sep 9, 2025, 16:22 PM -
Does the Joint Clinical Assessment (JCA) Enable Health Equity Across Europe? A Review of HTA Practices in the EU
Sep 9, 2025, 16:22 PM -
The Use of Oligometastatic Disease in Routine Radiology Practice: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM
